PA
SARO

PharVision Advisers’s StandardAero Inc SARO Stock Holding History

PharVision Advisers’s Portfolio SARO Stock Details SARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,083
Closed -$319K – 826
2025
Q2 		$319K Buy
+10,083
New +$283K 0.46% 70

Other funds holding SARO

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PharVision Advisers's SARO Position: Q3 2025 in Review

PharVision Advisers sold out of StandardAero Inc (SARO) in Q3 2025, closing a stake of 10,083 shares — an estimated $319K sold.

PharVision Advisers first reported a position in SARO in Q2 2025 and held it in 1 quarter. The position peaked at $319K in Q2 2025. 233 funds tracked by Wall St. Rank hold SARO as of Q3 2025.

  • PharVision Advisers reported no remaining StandardAero Inc position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 10,083 StandardAero Inc shares in Q3 2025, an estimated $319K.
  • PharVision Advisers first reported a position in StandardAero Inc in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's StandardAero Inc position peaked at $319K in Q2 2025.
  • 233 funds tracked by Wall St. Rank held StandardAero Inc as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.